Δημοσίευση

Update of the European guidelines for basal cell carcinoma management.

ΤίτλοςUpdate of the European guidelines for basal cell carcinoma management.
Publication TypeJournal Article
Year of Publication2014
AuthorsTrakatelli, M., Morton C., Nagore E., Ulrich C., Del Marmol V., Peris K., & Basset-Seguin N.
Corporate AuthorsBCC subcommittee of the Guidelines Committee of the European Dermatology Forum
JournalEur J Dermatol
Volume24
Issue3
Pagination312-29
Date Published2014 May-Jun
ISSN1952-4013
Λέξεις κλειδιάAminoquinolines, Antineoplastic Agents, Carcinoma, Basal Cell, Dermatologic Surgical Procedures, Humans, Imiquimod, Photochemotherapy, Skin Neoplasms
Abstract

BACKGROUND: European guidelines for the management of basal cell carcinoma (BCC) prepared by the former BCC subcommittee of the Guidelines Committee of the European Dermatology Forum (EDF) were published in 2006.OBJECTIVES: To present updated guidelines that include consensual expert definitions on various BCC types, prognosis and risk factors for BCC as well as review recommendations for diagnosis and treatment reflecting current published evidence.METHODS: These guidelines (S1 type) were prepared by the new BCC subgroup of the European Dermatology Forum (EDF)'s Guidelines Committee through extensive literature review (up to 2012) and expert experience; they were extensively discussed within the EDF subcommittee and approved by peer reviewers of the EDF. Results BCC is a common tumour with an incidence rising worldwide. Three major clinical types of BCC are recognized: nodular, superficial and morpheaform. Four histological subtypes are defined: superficial, nodular, infiltrative and morpheaform. On the basis of the risk of relapse, three prognosis groups have been identified: high, intermediate and low risk. According to these classifications and evidence-based evaluation of the therapeutic strategies available, a decision tree is proposed for the management of BCCs.CONCLUSIONS: The guidelines offer a useful tool that will help dermatologists to select the most appropriate treatment for individual patients.

DOI10.1684/ejd.2014.2271
Alternate JournalEur J Dermatol
PubMed ID24723647

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.